NeuroMetrix Inc., a Waltham-based medical device company, said Monday that it has started commercial shipment of its SENSUS Pain Management System, a device that helps manage chronic pain in the lower leg or foot.
The system is a lightweight electrical nerve stimulator that is worn on the upper calf and activated by the press of a button. According to the company’s website, trancutaneous electrical nerve stimulation has been shown to provide pain relief for patients with diabetes.
The system received final clearance from the Food and Drug Administration in November, the company noted in a press release.
“SENSUS was designed to address the clinical and lifestyle needs of people with diabetes,” Shai N. Gozani, the company’s president and chief executive, said in a statement. “Therefore, we believe that physicians treating patients with painful diabetic neuropathy, a severe and debilitating form of chronic pain, may find SENSUS to be a useful therapeutic option. We are pleased to be partnering with a growing network of durable medical equipment suppliers who will be responsible for physician detailing, supplying product to patients, and insurance billing. This will allow us to focus on our areas of expertise which include product development, marketing programs, and clinical studies.”